Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Mild to Moderate Ulcerative Colitis
NCT00065065Phase 2Completed
- Sponsor
- James Lewis Recruitment
- Start
- Sep 2002
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in ulcerative colitis (UC), sponsored by James Lewis Recruitment. Started Sep 2002; status: completed.
02
Drugs
rosiglitazone
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00065065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065065.